Aradigm Corporation - Company & Market Research Reports

Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. The company’s lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq (ARD-3150) and Lipoquin (ARD-3100) that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis and cystic fibrosis. Aradigm Corporation was founded in 1991 and is headquartered in Hayward, California.

Global Smoking Cessation Drugs Market 2016-2020 - Product Thumbnail Image

Global Smoking Cessation Drugs Market 2016-2020

  • Report
  • 74 Pages
From
Bronchiectasis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Bronchiectasis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 88 Pages
From
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) - Product Thumbnail Image

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

  • Report
  • 220 Pages
From
Cystic Fibrosis: Epidemiology Overview and Insights - Product Thumbnail Image

Cystic Fibrosis: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Market Intelligence Review and Insights - Product Thumbnail Image

COPD: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Smoking Addiction - Pipeline Review, H2 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H2 2017

  • Report
  • 89 Pages
From
Global Respiratory Drug Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Respiratory Drug Market Research and Forecast 2018-2023

  • Report
From
Smoking Addiction - Pipeline Review, H1 2017 - Product Thumbnail Image

Smoking Addiction - Pipeline Review, H1 2017

  • Report
  • 86 Pages
From
Addiction - Pipeline Review, H2 2015 - Product Thumbnail Image

Addiction - Pipeline Review, H2 2015

  • Report
  • 369 Pages
From
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems - Product Thumbnail Image

Drug Delivery Markets, Vol III: Pulmonary Delivery Systems

  • Report
  • 132 Pages
From
Bronchiectasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Bronchiectasis - Pipeline Review, H1 2018

  • Report
  • 75 Pages
From
Bronchiectasis - Pipeline Review, H2 2017 - Product Thumbnail Image

Bronchiectasis - Pipeline Review, H2 2017

  • Report
  • 73 Pages
From
Alzheimer's: Pipeline Assessment and Insights - Product Thumbnail Image

Alzheimer's: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 - Product Thumbnail Image

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018

  • Report
  • 35 Pages
From
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018 - Product Thumbnail Image

Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018

  • Report
  • 30 Pages
From
Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025

  • Report
  • 143 Pages
From
Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems) - Product Thumbnail Image

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

  • Report
  • 475 Pages
From
Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Product Thumbnail Image

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021

  • Report
  • 382 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2018 - Product Thumbnail Image

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2018

  • Report
  • 350 Pages
From
Loading Indicator
adroll